Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on June 24, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Calibration and Quality Assurance Services for High-Throughput Sequencers

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541380
New
International
PS26239 - RAF015/2627 - Plug-in batteries safety study
Solicitation # PS26239
The Department for Energy Security & Net Zero, through UK Shared Business Services, is seeking a provider to conduct a safety study on plug-in batteries with up to 800 W AC mains output for domestic use in the UK. The primary objective is to generate independent technical evidence to inform the legalisation of these batteries under the Plugs and Sockets etc. (Safety) Regulations 1994 and the Electricity Safety, Quality and Continuity Regulations 2002. The project is divided into two phases, with Phase 1 focusing on desk-based research and lab-based tests to evaluate fire and electrical safety risks across various installation configurations, including standalone units and DC-coupled systems. Phase 2 may extend research to conventional electrician-installed home battery systems to refine existing standards. The contract has an estimated budget of 300,000 GBP excluding VAT, with a performance period running from November 9, 2026, to March 31, 2028. Bidders must utilize reputable test facilities, preferably with UKAS accreditation, and adhere to recognized standards such as BS EN 62619. Evaluation is based on a combination of commercial and non-commercial criteria, with a mandatory minimum quality threshold of 60 for the facilities and flexibility requirement. All bids must be submitted via the Jaggaer eSourcing Portal by October 7, 2026, at 11:00. Compliance with Government Security Classifications and the Modern Slavery Act 2015 is required.
Department for Energy Security & Net Zero

POSTED

1 day ago

DEADLINE

in 25 days

AI Contract Overview

Show more

The contract provides for annual calibration visits and comprehensive quality assurance services for next-generation sequencing platforms used in FDA research laboratories. These services include performance verification, precision alignment checks, and detailed quality control reporting to ensure ongoing instrument accuracy and reliability in genomic data generation. The work is mandated to support regulatory research integrity and is scoped to maintain high standards required for FDA-approved research output. The services are to be performed at a facility located in Jefferson with a zip code of 72079, and the contract falls under NAICS code 541380 for scientific and technical consulting services. It is classified as a subcontract with a response deadline of July 3, 2026, at 6:00 PM, and was posted on June 24, 2026. The contract is managed under the Department of Health and Human Services through the FDA Office of Acquisition and Grant Services, with no set-aside provisions specified, indicating it is open to eligible subcontractors without demographic or size restrictions.

General Info

Annual calibration and quality assurance for FDA sequencing platforms in Jefferson, 72079, under NAICS 541380.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

541380 - Testing Laboratories and ServicesView NAICS

Place of Performance

Jefferson, AR, 72079, USA

Set-Aside

NONE

Documents

This scope was carved out of 75F40126Q133839.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

NextSeq Sequencing System Corrective/Remedial Repair and Preventive Maintenance Service

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Annual calibration visits with performance verification, alignment checks, and quality control reporting for NGS platforms in FDA research labs.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS